NIH launches clinical trial of three mRNA HIV vaccines
Phase-I study is amongst the first to examine mRNA technology for HIV
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Category
Research
GeoVax vaccine targetting virus in two places shows promise; virus may become resistant to antibody…
GeoVax's GEO-CM04S1 induces immune responses that target the spike protein on the surface of the virus. However, it also targets…
COVID vax prevents infection, severe disease in kidney dialysis patients: Study
In the study, individuals who had received a single COVID vaccine dose were 41 per cent less likely to become infected with…
NIH launches trial to study allergic reactions to COVID-19 mRNA vaccine
The trial is seeking participants who experienced a mild or moderate systemic allergic reaction following the first dose of either…
Arthritis drug shown to reduce risk of COVID death in large UK trial
More than 8,000 patients were administered baricitinib in addition to usual care, at random, or usual care alone, as part of the…
Decision on mixing and matching of booster dose of COVID vaccines will be based on science:…
Addressing a press conference, V K Paul, member (health), NITI Aayog, said studies are going on regarding the mixing and matching…
Roche teams up with research institutions for new Alzheimer’s trial
The trial aims to evaluate the potential of gantenerumab to slow disease progression in people with the earliest biological signs…
Study finds Neem tree-based drugs may help fight against COVID
The study, led by a team from the Indian Institute of Science Education and Research, Kolkata, shows that components of Neem bark…
Inovio lab tests show COVID vaccine weaker against Omicron, trial enrollment paused
Inovio has paused enrollment in the trial to prepare for this potential change, and said interim efficacy data from the trial will…
Indian, Australian researchers devise math model to predict COVID vaccine efficacy
The model can potentially optimise the use of available vaccines and speed up the development of new ones
GSK provides update on phase-III RSV maternal vaccine candidate
The company has decided to stop enrollment and vaccination in trials evaluating its potential Respiratory Syncytial Virus (RSV)…
Pfizer/BioNTech COVID vaccine less effective in kids aged five to 11 years: New York study
The vaccine's efficacy against infection among those children declined to 12 per cent at the end of January from 68 per cent in…
SII seeks permission for phase-III study of Covovax as booster dose in adults
The Drugs Controller General Of India (DCGI) had approved Covovax for restricted use in emergency situations in adults on 28th…
Bharat Biotech working on TB vaccine, to ink pact with a firm for technology
Without providing details on the name of the firm with which Bharat Biotech will be inking MoU, Krishna Ella, Chairman and MD of…
Sirnaomics announces interim data from phase-II clinical trial of STP705 to treat cutaneous BCC
The interim data, which examines results from three cohorts with 15 total subjects, shows a dose response with complete response,…
COVID vaccine doesn’t raise risk of rare inflammation in children: Lancet
The reporting rate of MIS-C for those without evidence of SARS-CoV-2 infection was 0.3 cases per million vaccinated individuals
Sanofi and GSK to seek regulatory authorisation for COVID-19 vaccine
Final analysis of the global VAT02 booster trial confirms universal ability to boost neutralising antibodies 18-to 30-fold across…
Probiotic capsules may speed up COVID recovery, says study
Probiotics are over-the-counter tablets and drinks said to bolster the gut microbiome, the complex intestinal 'soup' made up of…
Clinical trials market worth $52 billion by 2026: MarketsandMarkets report
The factors such as growing R&D expenditure, increasing outsourcing of R&D activities and the rising number of clinical…
Enhertu improves both progression-free and overall survival in Destiny-Breast04 trial in patients…
First HER2-low metastatic breast cancer phase-III results for AstraZeneca and Daiichi Sankyo’s Enhertu offer potential to redefine…